Therapy News and Research

RSS

Pairing antiviral therapy with immune modulation restores lung repair in lethal Influenza

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.

20 Nov 2025

AGA issues updated guidance for pharmacologic treatment of moderate-to-severe Crohn's disease

The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease.

20 Nov 2025

Researchers develop wearable microwave devices for fast and accessible health monitoring

At the University of Oulu, researchers are exploring new ways to utilize microwave technology in monitoring and assessing health conditions.

20 Nov 2025

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects

GLP-1 receptor agonists improve glycaemic control and provide renal, metabolic, and selective cardiovascular benefits in people with type 2 diabetes, based on an umbrella review of 17 meta-analyses. However, these agents consistently increase gastrointestinal adverse effects and show important distinctions between class-level outcomes and individual drug effects, particularly for semaglutide.

20 Nov 2025

Study uncovers promising therapeutic strategies against neuroendocrine prostate cancer

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

20 Nov 2025

Evaluating the role of stereotactic radiosurgery in craniopharyngioma management

Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign histology, their location near the hypothalamus, pituitary gland, and optic pathways complicates management.

19 Nov 2025

EULAR develops new disease activity score for antiphospholipid syndrome

EULAR - The European Alliance of Associations for Rheumatology - has developed a new disease activity score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS).

19 Nov 2025

Cancer cells hijack cell death enzyme to regrow after treatment

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it.

19 Nov 2025

New NIH grants support research on how brain fluid movement drives glioblastoma spread

Jennifer Munson, a cancer researcher at Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded two new National Institutes of Health grants to advance greater understanding and improved treatment of a deadly brain cancer.

19 Nov 2025

Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small fraction of patients.

19 Nov 2025

Integrated financial and mental health programs offer stronger benefits

Supporting people with both financial and mental health support at the same time works better than tackling either one in isolation, according to new research led by the London School of Economics and Political Science (LSE).

19 Nov 2025

Expert panel recommends new antibiotic strategies for resistant Bordetella pertussis

Pertussis, or whooping cough, remains a highly contagious respiratory infection caused by Bordetella pertussis. Despite inclusion of pertussis vaccines in immunization programs since the 1970s, outbreaks have re-emerged globally due to waning immunity and bacterial evolution.

19 Nov 2025

AI analysis of biopsy slides predicts rectal cancer treatment response

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers at UCL and UCLH.

19 Nov 2025

Breakthrough in FcγRI inhibition opens path to safer autoimmune therapies

An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that specifically block the high-affinity IgG receptor FcγRI.

19 Nov 2025

Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages

Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications.

19 Nov 2025

Longest survival in the world reported to date for multiple myeloma patients

Berenson Cancer Center published survival data analyzed by the Institute for Myeloma & Bone Cancer Research of 175 consecutive and unselected patients with multiple myeloma in the journal Haematologica.

19 Nov 2025

New antibody strategy shows promise for halting cyst growth in polycystic kidney disease

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the painful, growing cysts rob the organs of their function, often leading to dialysis in advanced cases.

18 Nov 2025

Tirzepatide reveals a brain signal that predicts returning food preoccupation

Researchers implanted electrodes in the human nucleus accumbens to track brain activity during severe food preoccupation in an individual taking tirzepatide. They found that a delta–theta biomarker disappeared during symptom-free periods and re-emerged weeks before relapse, suggesting a possible neural marker of vulnerability to dysregulated eating.

18 Nov 2025

Novel therapy reduces tumor growth in models of triple-negative breast cancer

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.

18 Nov 2025

Encapsulated hormone therapy strengthens osteoporotic bones while avoiding side effects

Postmenopausal osteoporosis is a condition that weakens bones, making them brittle and prone to fracture.

18 Nov 2025

Therapy News and Research

Pairing antiviral therapy with immune modulation restores lung repair in lethal Influenza

AGA issues updated guidance for pharmacologic treatment of moderate-to-severe Crohn's disease

Researchers develop wearable microwave devices for fast and accessible health monitoring

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects

Study uncovers promising therapeutic strategies against neuroendocrine prostate cancer

Evaluating the role of stereotactic radiosurgery in craniopharyngioma management

EULAR develops new disease activity score for antiphospholipid syndrome

Cancer cells hijack cell death enzyme to regrow after treatment

New NIH grants support research on how brain fluid movement drives glioblastoma spread

Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance

Integrated financial and mental health programs offer stronger benefits

Expert panel recommends new antibiotic strategies for resistant Bordetella pertussis

AI analysis of biopsy slides predicts rectal cancer treatment response

Breakthrough in FcγRI inhibition opens path to safer autoimmune therapies

Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages

Longest survival in the world reported to date for multiple myeloma patients

New antibody strategy shows promise for halting cyst growth in polycystic kidney disease

Tirzepatide reveals a brain signal that predicts returning food preoccupation

Novel therapy reduces tumor growth in models of triple-negative breast cancer

Encapsulated hormone therapy strengthens osteoporotic bones while avoiding side effects

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News